Quick Dispatch:
Your tirzepatide surmount 1 Tirzepatide for Obesity: Highlights from the SURMOUNT-1 Trial orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your tirzepatide surmount 1 Tirzepatide for Obesity: Highlights from the SURMOUNT-1 Trial ships.
Need Help?
Questions about tirzepatide surmount 1 Tirzepatide for Obesity: Highlights from the SURMOUNT-1 Trial, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for tirzepatide surmount 1 Tirzepatide for Obesity: Highlights from the SURMOUNT-1 Trial in your area.
SURMOUNT-1 Trial
21.31
Effect of tirzepatide in SURMOUNT-1 trial. (BMI: body mass index; CI:
27.92
SURMOUNT 1 // Three-Year Obesty & Diabetes Prevention Outcomes
28.76
Tirzepatide Demonstrates 94% Diabetes Reduction, 22% Weight Loss in SURMOUNT -1 Study
28.99
SURMOUNT‐1 study design. This is a phase 3, multicenter, randomized,
22.37
Tirzepatide for Obesity Treatment and Diabetes Prevention
24.90
01200-X/asset/429e6fd1-61d1-402a-91a5-b2ec86b1b878/main.assets/gr2_lrg.jpg "Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial")
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
21.70
